Dr. Dhinakar M45 Validation of a Secure Ultrasound Imaging (Distributed Intelligent Ultrasound Imaging System for Secure Diagnostics: SecureUltrasound), against the Gold Standard
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2025
Project Lead
Authors
Dr. Dhinakar
Project Status
completed
Project Type
icmr